💊
Isturisa
osilodrostat
Cushing Syndrome
✅ Authorised
✅
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Isturisa is indicated for the treatment of endogenous Cushing’s syndrome in adults.
⚠️ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/isturisa